130 related articles for article (PubMed ID: 37985144)
21. Development of a perfusion process for continuous lentivirus production using stable suspension producer cell lines.
Klimpel M; Terrao M; Ching N; Climenti V; Noll T; Pirzas V; Laux H
Biotechnol Bioeng; 2023 Sep; 120(9):2622-2638. PubMed ID: 37148430
[TBL] [Abstract][Full Text] [Related]
22. Depth filter material process interaction in the harvest of mammalian cells.
Parau M; Pullen J; Bracewell DG
Biotechnol Prog; 2023; 39(3):e3329. PubMed ID: 36775837
[TBL] [Abstract][Full Text] [Related]
23. PDADMAC flocculation of Chinese hamster ovary cells: enabling a centrifuge-less harvest process for monoclonal antibodies.
McNerney T; Thomas A; Senczuk A; Petty K; Zhao X; Piper R; Carvalho J; Hammond M; Sawant S; Bussiere J
MAbs; 2015; 7(2):413-28. PubMed ID: 25706650
[TBL] [Abstract][Full Text] [Related]
24. Establishing functional lentiviral vector production in a stirred bioreactor for CAR-T cell therapy.
Tang QL; Gu LX; Xu Y; Liao XH; Zhou Y; Zhang TC
Bioengineered; 2021 Dec; 12(1):2095-2105. PubMed ID: 34047682
[TBL] [Abstract][Full Text] [Related]
25. Toward a Scalable Purification Protocol of GaLV-TR-Pseudotyped Lentiviral Vectors.
Boudeffa D; Bertin B; Biek A; Mormin M; Leseigneur F; Galy A; Merten OW
Hum Gene Ther Methods; 2019 Oct; 30(5):153-171. PubMed ID: 31516018
[TBL] [Abstract][Full Text] [Related]
26. Transition from serum-supplemented monolayer to serum-free suspension lentiviral vector production for generation of chimeric antigen receptor T cells.
Tirapelle MC; Oliveira Lomba AL; Silvestre RN; Mizukami A; Covas DT; Picanço-Castro V; Swiech K
Cytotherapy; 2022 Aug; 24(8):850-860. PubMed ID: 35643755
[TBL] [Abstract][Full Text] [Related]
27. Large-scale production means for the manufacturing of lentiviral vectors.
Schweizer M; Merten OW
Curr Gene Ther; 2010 Dec; 10(6):474-86. PubMed ID: 21054245
[TBL] [Abstract][Full Text] [Related]
28. A single-use purification process for the production of a monoclonal antibody produced in a PER.C6 human cell line.
Kuczewski M; Schirmer E; Lain B; Zarbis-Papastoitsis G
Biotechnol J; 2011 Jan; 6(1):56-65. PubMed ID: 21170980
[TBL] [Abstract][Full Text] [Related]
29. Clinical grade lentiviral vector purification and quality control requirements.
Shi R; Jia S; Liu H; Nie H
J Sep Sci; 2022 Jun; 45(12):2093-2101. PubMed ID: 35247228
[TBL] [Abstract][Full Text] [Related]
30. Cost-efficient cell clarification using an intensified fluidized bed centrifugation platform approach.
Saballus M; Filz TJ; Pollard D; Kampmann M
Biotechnol Bioeng; 2023 Jun; ():. PubMed ID: 37334463
[TBL] [Abstract][Full Text] [Related]
31. Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors.
Lesch HP; Laitinen A; Peixoto C; Vicente T; Makkonen KE; Laitinen L; Pikkarainen JT; Samaranayake H; Alves PM; Carrondo MJ; Ylä-Herttuala S; Airenne KJ
Gene Ther; 2011 Jun; 18(6):531-8. PubMed ID: 21248790
[TBL] [Abstract][Full Text] [Related]
32. Production of lentiviral vectors in suspension cells using low proportion of supercoiled circular plasmid DNA.
Lu XA; He T; Han Z; Ding Y; Zhao L; Liu G; De Smet F; Huang X; Chen D; Qi F; Zhao X
Cytotechnology; 2020 Oct; 72(6):897-905. PubMed ID: 33123933
[TBL] [Abstract][Full Text] [Related]
33. Exploitation of the adsorptive properties of depth filters for host cell protein removal during monoclonal antibody purification.
Yigzaw Y; Piper R; Tran M; Shukla AA
Biotechnol Prog; 2006; 22(1):288-96. PubMed ID: 16454522
[TBL] [Abstract][Full Text] [Related]
34. Rapid In-Process Monitoring of Lentiviral Vector Particles by High-Performance Liquid Chromatography.
Transfiguracion J; Tran MY; Lanthier S; Tremblay S; Coulombe N; Acchione M; Kamen AA
Mol Ther Methods Clin Dev; 2020 Sep; 18():803-810. PubMed ID: 32953931
[TBL] [Abstract][Full Text] [Related]
35. Highly efficient large-scale lentiviral vector concentration by tandem tangential flow filtration.
Cooper AR; Patel S; Senadheera S; Plath K; Kohn DB; Hollis RP
J Virol Methods; 2011 Oct; 177(1):1-9. PubMed ID: 21784103
[TBL] [Abstract][Full Text] [Related]
36. Phase I/II Manufacture of Lentiviral Vectors Under GMP in an Academic Setting.
Dasgupta A; Tinch S; Szczur K; Ernst R; Shryock N; Kaylor C; Lewis K; Day E; Truong T; Swaney W
Methods Mol Biol; 2020; 2086():27-60. PubMed ID: 31707666
[TBL] [Abstract][Full Text] [Related]
37. Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector.
Grieger JC; Soltys SM; Samulski RJ
Mol Ther; 2016 Feb; 24(2):287-297. PubMed ID: 26437810
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a single-use disk stack centrifuge for improved efficiency and sustainability at 1000 L GMP manufacturing scale.
Walker J; Lam Y; Loman A; Smelko JP; Rohr M
Biotechnol Bioeng; 2023 Nov; 120(11):3347-3356. PubMed ID: 37539666
[TBL] [Abstract][Full Text] [Related]
39. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification.
Segura MM; Garnier A; Durocher Y; Coelho H; Kamen A
Biotechnol Bioeng; 2007 Nov; 98(4):789-99. PubMed ID: 17461423
[TBL] [Abstract][Full Text] [Related]
40. Pretreatments for enhancing clarification efficiency of depth filtration during production of monoclonal antibody therapeutics.
Hadpe SR; Mohite V; Alva S; Rathore AS
Biotechnol Prog; 2020 Sep; 36(5):e2996. PubMed ID: 32223061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
